H.U. Group Holdings, Inc. (MRCHF)
USD 15.97
(0.0%)
USD 15.97
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 16.82 Billion JPY | -68.23% |
| 2023 | 42.97 Billion JPY | -31.95% |
| 2022 | 56.34 Billion JPY | 66.21% |
| 2021 | 36.96 Billion JPY | 105.04% |
| 2020 | 17.67 Billion JPY | -14.36% |
| 2019 | 21.27 Billion JPY | -61.03% |
| 2018 | 2.88 Billion JPY | 35.04% |
| 2017 | 39.99 Billion JPY | 1.55% |
| 2016 | 39.38 Billion JPY | -7.11% |
| 2015 | 42.39 Billion JPY | 0.42% |
| 2014 | 41.23 Billion JPY | 4.37% |
| 2013 | 39.63 Billion JPY | 11.98% |
| 2012 | 36.12 Billion JPY | 10.66% |
| 2011 | 32.64 Billion JPY | 9.42% |
| 2010 | 29.83 Billion JPY | 11.57% |
| 2009 | 25.79 Billion JPY | 6.2% |
| 2008 | 25.17 Billion JPY | 4.03% |
| 2007 | 23.53 Billion JPY | -61.53% |
| 2006 | 22 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - JPY | -59.75% |
| 2024 Q1 | 4.03 Billion JPY | -17.42% |
| 2024 Q2 | 5.26 Billion JPY | 53.93% |
| 2024 Q3 | 5.56 Billion JPY | -31.85% |
| 2024 Q4 | 2.57 Billion JPY | -28.38% |
| 2023 Q3 | 10.47 Billion JPY | -26.16% |
| 2023 FY | - JPY | -31.95% |
| 2023 Q4 | 4.14 Billion JPY | -60.43% |
| 2023 Q1 | 12.99 Billion JPY | -20.76% |
| 2023 Q2 | 14.18 Billion JPY | 9.13% |
| 2022 Q1 | 14.75 Billion JPY | 35.0% |
| 2022 Q2 | 17.78 Billion JPY | 20.57% |
| 2022 FY | - JPY | 66.21% |
| 2022 Q3 | 12.48 Billion JPY | -29.79% |
| 2022 Q4 | 16.4 Billion JPY | 31.36% |
| 2021 Q1 | 3.31 Billion JPY | -2.87% |
| 2021 Q4 | 10.92 Billion JPY | -13.49% |
| 2021 Q3 | 12.63 Billion JPY | 25.29% |
| 2021 FY | - JPY | 105.04% |
| 2021 Q2 | 10.08 Billion JPY | 203.77% |
| 2020 FY | - JPY | -14.36% |
| 2020 Q1 | 5.09 Billion JPY | 15.92% |
| 2020 Q2 | 5.02 Billion JPY | -1.43% |
| 2020 Q3 | 4.49 Billion JPY | -10.61% |
| 2020 Q4 | 3.41 Billion JPY | -23.9% |
| 2019 Q4 | 4.39 Billion JPY | -29.1% |
| 2019 Q3 | 6.2 Billion JPY | 16.24% |
| 2019 FY | - JPY | -61.03% |
| 2019 Q1 | 5.11 Billion JPY | 31.37% |
| 2019 Q2 | 5.33 Billion JPY | 4.22% |
| 2018 Q2 | 8.08 Billion JPY | -15.96% |
| 2018 Q4 | 3.89 Billion JPY | -87.98% |
| 2018 Q1 | 9.62 Billion JPY | 12.0% |
| 2018 FY | - JPY | 35.04% |
| 2018 Q3 | 32.4 Billion JPY | 300.72% |
| 2017 Q2 | 10.5 Billion JPY | 7.27% |
| 2017 FY | - JPY | 1.55% |
| 2017 Q4 | 8.59 Billion JPY | -22.6% |
| 2017 Q3 | 11.1 Billion JPY | 5.64% |
| 2017 Q1 | 9.79 Billion JPY | 16.58% |
| 2016 Q2 | 10.41 Billion JPY | 2.17% |
| 2016 Q1 | 10.19 Billion JPY | 8.27% |
| 2016 Q4 | 8.4 Billion JPY | -18.92% |
| 2016 Q3 | 10.36 Billion JPY | -0.55% |
| 2016 FY | - JPY | -7.11% |
| 2015 Q1 | 10.53 Billion JPY | 6.62% |
| 2015 FY | - JPY | 0.42% |
| 2015 Q4 | 9.41 Billion JPY | -13.98% |
| 2015 Q3 | 10.95 Billion JPY | -4.72% |
| 2015 Q2 | 11.49 Billion JPY | 9.1% |
| 2014 Q4 | 9.88 Billion JPY | -7.62% |
| 2014 FY | - JPY | 4.37% |
| 2014 Q1 | 10.59 Billion JPY | 16.06% |
| 2014 Q2 | 11.05 Billion JPY | 4.34% |
| 2014 Q3 | 10.69 Billion JPY | -3.23% |
| 2013 Q2 | 9.84 Billion JPY | -11.14% |
| 2013 Q4 | 9.12 Billion JPY | -12.32% |
| 2013 FY | - JPY | 11.98% |
| 2013 Q1 | 11.07 Billion JPY | 17.14% |
| 2013 Q3 | 10.4 Billion JPY | 5.75% |
| 2012 FY | - JPY | 10.66% |
| 2012 Q2 | 8.75 Billion JPY | 0.56% |
| 2012 Q3 | 9.21 Billion JPY | 5.21% |
| 2012 Q4 | 9.45 Billion JPY | 2.66% |
| 2012 Q1 | 8.7 Billion JPY | 14.3% |
| 2011 Q4 | 7.61 Billion JPY | -9.57% |
| 2011 FY | - JPY | 9.42% |
| 2011 Q1 | 8.59 Billion JPY | 31.93% |
| 2011 Q3 | 8.42 Billion JPY | 5.01% |
| 2011 Q2 | 8.02 Billion JPY | -6.69% |
| 2010 Q3 | 7.97 Billion JPY | 1.31% |
| 2010 Q1 | 7.49 Billion JPY | 11.97% |
| 2010 Q4 | 6.51 Billion JPY | -18.26% |
| 2010 FY | - JPY | 11.57% |
| 2010 Q2 | 7.86 Billion JPY | 4.98% |
| 2009 Q4 | 6.69 Billion JPY | -4.45% |
| 2009 Q3 | 7 Billion JPY | 69.61% |
| 2009 Q2 | 4.13 Billion JPY | 0.0% |
| 2009 FY | - JPY | 6.2% |
| 2008 FY | - JPY | 4.03% |
| 2007 FY | - JPY | -61.53% |
| 2006 FY | - JPY | 0.0% |
| 2005 Q4 | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 1446875.58% |
| Arrayit Corporation | -3.07 Million USD | 546843.374% |
| Atlantic International Corp. | -5.38 Million USD | 312296.172% |
| Biocept, Inc. | -30.24 Million USD | 55739.694% |
| Bioqual, Inc. | 3.03 Million USD | -554803.306% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 2221720.729% |
| DermTech, Inc. | -97.89 Million USD | 17288.154% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | -477.396% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 83222.316% |
| iMD Companies, Inc. | -154.65 Thousand USD | 10879518.592% |
| IDenta Corp. | 71.58 Thousand USD | -23504167.535% |
| Interpace Biosciences, Inc. | 3.83 Million USD | -438419.677% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -43489173.714% |
| InVitro International | 6680.00 USD | -251886127.545% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 309629.065% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 138668305.044% |
| Medical Imaging Corp. | -896.74 Thousand USD | 1876447.935% |
| NovelStem International Corp. | -3.78 Million USD | 444550.432% |
| Optigenex Inc. | -1.18 Million USD | 1417952.845% |
| PharmChem, Inc. | 1.05 Million USD | -1596582.514% |
| Proteome Sciences plc | -1.13 Million USD | 1479959.279% |
| Response Genetics, Inc | -19.66 Million USD | 85658.833% |
| Rennova Health, Inc. | -234.81 Thousand USD | 7165741.037% |
| RushNet, Inc. | -614.85 Thousand USD | 2736693.522% |
| ScreenPro Security Inc. | -3.43 Million USD | 489955.713% |
| Stella Diagnostics Inc. | -5.7 Million USD | 294908.697% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 163934.183% |
| Todos Medical Ltd. | -9.39 Million USD | 179214.328% |